Litcius/Paper detail

Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma

Junichi Shindoh, Yusuke Kawamura, Masahiro Kobayashi, Norio Akuta, Satoshi Okubo, Masaru Matsumura, Yoshiyuki Suzuki, Masaji Hashimoto

2022Journal of Gastrointestinal Surgery15 citationsDOI

Topics & Concepts

MedicineLenvatinibHepatocellular carcinomaPsychological interventionOncologyInternal medicineIntensive care medicineSorafenibPsychiatryHepatocellular Carcinoma Treatment and PrognosisCancer Mechanisms and TherapyCholangiocarcinoma and Gallbladder Cancer Studies
Prognostic Advantages of Individual Additional Interventions After Lenvatinib Therapy in Patients with Advanced Hepatocellular Carcinoma | Litcius